Pfizer Inc. has divulged 3C-like proteinase (3CLpro) (SARS-CoV-2) inhibitors reported to be useful for the treatment of SARS-CoV-2 infection (COVID-19).

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Novacyt, Radiaction, Transit Scientific.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 2seventy, Aquestive, Assertio, BMS, Ignyte, JW, Kissei, Obseva, Obsidian, Peak, Res Nova, Soligenix and Therapeutic Solutions.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acelrx, Aileron, Anixa, Astrazeneca, Atara, Biogen, BMS, Boehringer, Cocrystal, Codagenix, Corvus, Covis, Effector, Essa, Exelixis, Foghorn, Hepion, Horizon, Immutep, Jaguar, Kura, Merck, Merus, Morphic, Nurix, Olema, Oncopeptides, Redhill, Ryvu, Viiv.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biohaven and Candel.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Applied, Astrazeneca, Atai, Avrobio, Can-Fite, Cardiol, Gristone, Imaginab, Inotrem, Oblato, Quadriga, Seelos and Ultimovacs.

Sinocelltech Group Ltd. has reported positive interim data for two COVID-19 vaccine candidates, SCTV-01C and SCTV-01E, from phase III trials in the United Arab Emirates.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Acumen, Astrazeneca, Daiichi, JJP, Leo, Merck & Co., Novaliq, Novavax, Sensorion, Vanda, Vaxxinity.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alpine Immune, Bio-Path, Cincor, Matinas, Mirum, Morphic, NS, Novartis, Phathom, Scholar Rock, Step, Tricida, Vaxcyte, Vaxxinity, Viiv, Viridian, Zentalis.